Historically an inpatient procedure, total joint arthroplasties (TJAs) were recently removed from the U.S. Centers for Medicare & Medicaid Services’ inpatient-only list. Now the Brigham is leading the trend toward same-day discharge TJAs. Antonia F. Chen, MD, MBA, explains how the Brigham is managing this transition.

Grace X. Xiong, MD, Andrew K. Simpson, MD, MBA, and colleagues report disparities according to insurance type in baseline symptoms of lumbar disc herniation.

Mass General Brigham’s Antonia F. Chen, MD, MBA, Christina Liu, MD, and colleagues detail the effects of metabolic disease on total joint arthroplasty outcomes. They also reviewed the literature on preoperative management of osteoporosis, vitamin D deficiency, and diabetes mellitus.

Eli T. Sayegh, MD, Elizabeth G. Matzkin, MD, and colleagues recently set out to define the opioid requirement for all-inside ACLR. They report pain control with a multimodal analgesia regimen that included a limited opioid taper of 15 tablets for five days, which had no negative effect on patient satisfaction.

Several studies of patients undergoing joint arthroplasty and insured by Medicaid report systematically worse patient-reported outcome measures (PROMs) scores than patients with other insurance. Researchers at Brigham and Women’s Hospital found the same is true among patients with lumbar spinal stenosis.

Jeffrey N. Katz, MD, MS, Elena Losina, PhD, and colleagues found that structural changes in the knee detected after arthroscopic partial meniscectomy are not clinically meaningful during the first years of follow-up.